PIWIL2 drives the progression of non-small cell lung cancer through the induction of CDK2 and Cyclin A expression, thereby inhibiting apoptosis, and G2/M cycle arrest (Qu et al., 2015) (Figure 7D; Table 3). This evidence concerns the gene CDK2 and non-small cell lung carcinoma.